Filed: 7/22/2026ACC: 0001757283-26-000015
📋 What this filing means
ANDERA PARTNERS filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $206.48M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$206.48M
Total AUM (reported)
12.41M
Total Shares
Allocation by class
SHS$70.30M34.0%
COM SHS$49.11M23.8%
COM$42.95M20.8%
SPONSORED ADS$30.38M14.7%
ADS$13.73M6.7%
Portfolio Concentration
Top 3$142.98M69.2%
4–10$63.50M30.8%
Top 3 weight
69.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.41M
Sole
Full voting authority
12.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
KESTRA MED TECHNOLOGIES LTD
SOLEShares2.73M
TypeSH
Market value$69.42M
33.62%
Sole
2.73M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares1.59M
TypeSH
Market value$42.95M
20.80%
Sole
1.59M
Shared
0.00
None
0.00
AVALYN PHARMACEUTICALS INC
SOLEShares929.82K
TypeSH
Market value$30.61M
14.82%
Sole
929.82K
Shared
0.00
None
0.00
AGOMAB THERAPEUTICS NV
SOLEShares1.54M
TypeSH
Market value$19.97M
9.67%
Sole
1.54M
Shared
0.00
None
0.00
EVOMMUNE INC
SOLEShares1.39M
TypeSH
Market value$18.50M
8.96%
Sole
1.39M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares3.63M
TypeSH
Market value$13.73M
6.65%
Sole
3.63M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares78.13K
TypeSH
Market value$10.41M
5.04%
Sole
78.13K
Shared
0.00
None
0.00
NYXOAH S A
SOLEShares522.06K
TypeSH
Market value$882.3K
0.43%
Sole
522.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KESTRA MED TECHNOLOGIES LTDSOLE | SHS | 2.73M | SH | $69.42M 33.62% | 2.73M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 1.59M | SH | $42.95M 20.80% | 1.59M | 0.00 | 0.00 |
AVALYN PHARMACEUTICALS INCSOLE | COM SHS | 929.82K | SH | $30.61M 14.82% | 929.82K | 0.00 | 0.00 |
AGOMAB THERAPEUTICS NVSOLE | SPONSORED ADS | 1.54M | SH | $19.97M 9.67% | 1.54M | 0.00 | 0.00 |
EVOMMUNE INCSOLE | COM SHS | 1.39M | SH | $18.50M 8.96% | 1.39M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 3.63M | SH | $13.73M 6.65% | 3.63M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 78.13K | SH | $10.41M 5.04% | 78.13K | 0.00 | 0.00 |
NYXOAH S ASOLE | SHS | 522.06K | SH | $882.3K 0.43% | 522.06K | 0.00 | 0.00 |